Control Bionics Past Earnings Performance

Past criteria checks 0/6

Control Bionics's earnings have been declining at an average annual rate of -20.7%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 15.4% per year.

Key information


Earnings growth rate


EPS growth rate

Medical Equipment Industry Growth5.8%
Revenue growth rate15.4%
Return on equity-62.6%
Net Margin-84.4%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Companies Like Control Bionics (ASX:CBL) Are In A Position To Invest In Growth

Jan 19
Companies Like Control Bionics (ASX:CBL) Are In A Position To Invest In Growth

We're Hopeful That Control Bionics (ASX:CBL) Will Use Its Cash Wisely

Sep 17
We're Hopeful That Control Bionics (ASX:CBL) Will Use Its Cash Wisely

Revenue & Expenses Breakdown

How Control Bionics makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

ASX:CBL Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 236-590
30 Sep 236-590
30 Jun 236-690
31 Mar 235-680
31 Dec 225-680
30 Sep 225-680
30 Jun 225-680
31 Mar 224-680
31 Dec 214-680
30 Sep 214-570
30 Jun 214-450
30 Jun 203-130
30 Jun 191-220
30 Jun 181-110

Quality Earnings: CBL is currently unprofitable.

Growing Profit Margin: CBL is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: CBL is unprofitable, and losses have increased over the past 5 years at a rate of 20.7% per year.

Accelerating Growth: Unable to compare CBL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CBL is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).

Return on Equity

High ROE: CBL has a negative Return on Equity (-62.56%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.